Clinical trial

Relative Bioavailability Study of GSK1265744 Formulations

NCT01648257

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE1

Study timeline

Study start (unknown)2012-08-01Date precision: month

Registry last updated2016-08-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Infections, Human Immunodeficiency Virus and Hepatitisunresolved

Interventions

GSK1265744 Na Salt TabletsDRUG

GSK1265744 Free Acid Nanomilled CapsulesDRUG

GSK1265744 Free Acid Micronized CapsulesDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

Mapped research locations

Overland ParkKansas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01648257 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.